Answers are grounded in this paper and cite their sources.
The article, based on a literature review, discusses the criteria for metabolic syndrome, risk factors for its development, and the relationship with obesity and dyslipidemia. The role of lipids in the pathogenesis of metabolic syndrome and obesity is emphasized, as well as the risk of development and progression of atherosclerotic processes and cardiovascular events. In individuals with obesity, an atherogenic pattern of lipid profile abnormalities is observed in 40-52% of cases. Dyslipidemia associated with obesity and related conditions has specific characteristics, primarily linked to insulin resistance. It should be noted that the risk of developing metabolic complications increases with a waist circumference ≥80 cm in women and ≥94 cm in men. When diagnosing patients with obesity, a comprehensive range of clinical and laboratory tests should be performed to identify obesity-associated comorbidities and subsequently assess their severity. At the current stage, surgical treatment of patients with obesity is the most effective method for sustained weight reduction. Nevertheless, further research is needed to determine the most optimal therapeutic and preventive management strategies for patients with metabolic syndrome and obesity.
No takes yet. Share an insight, caveat, or question.
Igor V. Makarov (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: